Risks to human and animal health related to the presence of moniliformin in food and feed

Helle Katrine Knutsen, Jan Alexander, Lars Barregård, Margherita Bignami, Beat Brüschweiler, Sandra Ceccatelli, Bruce Cottrill, Michael Dinovi, Bettina Grasl-Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Carlo Stefano Nebbia, Isabelle P. Oswald, Annette Petersen, Martin Rose, Alain-Claude Roudot, Tanja Schwerdtle, Christiane Vleminckx, Günter Vollmer, Heather WallaceSarah De Saeger, Gunnar Sundstøl Eriksen, Peter Farmer, Jean-Marc Fremy, Yun Yun Gong, Karsten Meyer, Hanspeter Naegeli, Dominique Parent-Massin, Hans van Egmond, Andrea Altieri, Paolo Colombo, Mari Eskola, Mathijs van Manen, Lutz Edler, EFSA Panel on Contaminants in the Food Chain (CONTAM)

Research output: Contribution to journalArticle

10 Citations (Scopus)
4 Downloads (Pure)

Abstract

Moniliformin (MON) is a mycotoxin with low molecular weight primarily produced by Fusarium fungi and occurring predominantly in cereal grains. Following a request of the European Commission, the CONTAM Panel assessed the risk of MON to human and animal health related to its presence in food and feed. The limited information available on toxicity and on toxicokinetics in experimental and farm animals indicated haematotoxicity and cardiotoxicity as major adverse health effects of MON. MON causes chromosome aberrations in vitro but no in vivo genotoxicity data and no carcinogenicity data were identified. Due to the limitations in the available toxicity data, human acute or chronic health‐based guidance values (HBGV) could not be established. The margin of exposure (MOE) between the no‐observed‐adverse‐effect level (NOAEL) of 6.0 mg/kg body weight (bw) for cardiotoxicity from a subacute study in rats and the acute upper bound (UB) dietary exposure estimates ranged between 4,000 and 73,000. The MOE between the lowest benchmark dose lower confidence limit (for a 5% response ‐ BMDL05) of 0.20 mg MON/kg bw per day for haematological hazards from a 28‐day study in pigs and the chronic dietary human exposure estimates ranged between 370 and 5,000,000 for chronic dietary exposures. These MOEs indicate a low risk for human health but were associated with high uncertainty. The toxicity data available for poultry, pigs, and mink indicated a low or even negligible risk for these animals from exposure to MON in feed at the estimated exposure levels under current feeding practices. Assuming similar or lower sensitivity as for pigs, the CONTAM Panel considered a low or even negligible risk for the other animal species for which no toxicity data suitable for hazard characterisation were identified. Additional toxicity studies are needed and depending on their outcome, the collection of more occurrence data on MON in food and feed is recommended to enable a comprehensive human risk assessment.
Original languageEnglish
Article numbere05082
Number of pages95
JournalEFSA Journal
Volume16
Issue number3
Early online date2 Mar 2018
DOIs
Publication statusPublished - Mar 2018

Fingerprint

Food
Health
Swine
Body Weight
Mink
Benchmarking
Mycotoxins
Domestic Animals
Fusarium
Poultry
moniliformin
Chromosome Aberrations
Uncertainty
Fungi
Molecular Weight
Cardiotoxicity

Keywords

  • moniliformin
  • MON
  • exposure
  • toxicity
  • occurence
  • human and animal risk assessment

Cite this

Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B., Ceccatelli, S., ... EFSA Panel on Contaminants in the Food Chain (CONTAM) (2018). Risks to human and animal health related to the presence of moniliformin in food and feed. EFSA Journal, 16(3), [e05082]. https://doi.org/10.2903/j.efsa.2018.5082

Risks to human and animal health related to the presence of moniliformin in food and feed. / Knutsen, Helle Katrine ; Alexander, Jan; Barregård, Lars; Bignami, Margherita; Brüschweiler, Beat ; Ceccatelli, Sandra; Cottrill, Bruce; Dinovi, Michael; Grasl-Kraupp, Bettina ; Hogstrand, Christer ; Hoogenboom, Laurentius (Ron) ; Nebbia, Carlo Stefano ; Oswald, Isabelle P.; Petersen, Annette ; Rose, Martin ; Roudot, Alain-Claude ; Schwerdtle, Tanja ; Vleminckx, Christiane ; Vollmer, Günter ; Wallace, Heather; De Saeger, Sarah; Eriksen, Gunnar Sundstøl; Farmer, Peter; Fremy, Jean-Marc; Gong, Yun Yun; Meyer, Karsten; Naegeli, Hanspeter; Parent-Massin, Dominique ; van Egmond, Hans; Altieri, Andrea; Colombo, Paolo; Eskola, Mari; van Manen, Mathijs; Edler, Lutz; EFSA Panel on Contaminants in the Food Chain (CONTAM).

In: EFSA Journal, Vol. 16, No. 3, e05082, 03.2018.

Research output: Contribution to journalArticle

Knutsen, HK, Alexander, J, Barregård, L, Bignami, M, Brüschweiler, B, Ceccatelli, S, Cottrill, B, Dinovi, M, Grasl-Kraupp, B, Hogstrand, C, Hoogenboom, LR, Nebbia, CS, Oswald, IP, Petersen, A, Rose, M, Roudot, A-C, Schwerdtle, T, Vleminckx, C, Vollmer, G, Wallace, H, De Saeger, S, Eriksen, GS, Farmer, P, Fremy, J-M, Gong, YY, Meyer, K, Naegeli, H, Parent-Massin, D, van Egmond, H, Altieri, A, Colombo, P, Eskola, M, van Manen, M, Edler, L & EFSA Panel on Contaminants in the Food Chain (CONTAM) 2018, 'Risks to human and animal health related to the presence of moniliformin in food and feed', EFSA Journal, vol. 16, no. 3, e05082. https://doi.org/10.2903/j.efsa.2018.5082
Knutsen HK, Alexander J, Barregård L, Bignami M, Brüschweiler B, Ceccatelli S et al. Risks to human and animal health related to the presence of moniliformin in food and feed. EFSA Journal. 2018 Mar;16(3). e05082. https://doi.org/10.2903/j.efsa.2018.5082
Knutsen, Helle Katrine ; Alexander, Jan ; Barregård, Lars ; Bignami, Margherita ; Brüschweiler, Beat ; Ceccatelli, Sandra ; Cottrill, Bruce ; Dinovi, Michael ; Grasl-Kraupp, Bettina ; Hogstrand, Christer ; Hoogenboom, Laurentius (Ron) ; Nebbia, Carlo Stefano ; Oswald, Isabelle P. ; Petersen, Annette ; Rose, Martin ; Roudot, Alain-Claude ; Schwerdtle, Tanja ; Vleminckx, Christiane ; Vollmer, Günter ; Wallace, Heather ; De Saeger, Sarah ; Eriksen, Gunnar Sundstøl ; Farmer, Peter ; Fremy, Jean-Marc ; Gong, Yun Yun ; Meyer, Karsten ; Naegeli, Hanspeter ; Parent-Massin, Dominique ; van Egmond, Hans ; Altieri, Andrea ; Colombo, Paolo ; Eskola, Mari ; van Manen, Mathijs ; Edler, Lutz ; EFSA Panel on Contaminants in the Food Chain (CONTAM). / Risks to human and animal health related to the presence of moniliformin in food and feed. In: EFSA Journal. 2018 ; Vol. 16, No. 3.
@article{8d41cabde2c347b4a7aa2b70f8ebef90,
title = "Risks to human and animal health related to the presence of moniliformin in food and feed",
abstract = "Moniliformin (MON) is a mycotoxin with low molecular weight primarily produced by Fusarium fungi and occurring predominantly in cereal grains. Following a request of the European Commission, the CONTAM Panel assessed the risk of MON to human and animal health related to its presence in food and feed. The limited information available on toxicity and on toxicokinetics in experimental and farm animals indicated haematotoxicity and cardiotoxicity as major adverse health effects of MON. MON causes chromosome aberrations in vitro but no in vivo genotoxicity data and no carcinogenicity data were identified. Due to the limitations in the available toxicity data, human acute or chronic health‐based guidance values (HBGV) could not be established. The margin of exposure (MOE) between the no‐observed‐adverse‐effect level (NOAEL) of 6.0 mg/kg body weight (bw) for cardiotoxicity from a subacute study in rats and the acute upper bound (UB) dietary exposure estimates ranged between 4,000 and 73,000. The MOE between the lowest benchmark dose lower confidence limit (for a 5{\%} response ‐ BMDL05) of 0.20 mg MON/kg bw per day for haematological hazards from a 28‐day study in pigs and the chronic dietary human exposure estimates ranged between 370 and 5,000,000 for chronic dietary exposures. These MOEs indicate a low risk for human health but were associated with high uncertainty. The toxicity data available for poultry, pigs, and mink indicated a low or even negligible risk for these animals from exposure to MON in feed at the estimated exposure levels under current feeding practices. Assuming similar or lower sensitivity as for pigs, the CONTAM Panel considered a low or even negligible risk for the other animal species for which no toxicity data suitable for hazard characterisation were identified. Additional toxicity studies are needed and depending on their outcome, the collection of more occurrence data on MON in food and feed is recommended to enable a comprehensive human risk assessment.",
keywords = "moniliformin, MON, exposure, toxicity, occurence, human and animal risk assessment",
author = "Knutsen, {Helle Katrine} and Jan Alexander and Lars Barreg{\aa}rd and Margherita Bignami and Beat Br{\"u}schweiler and Sandra Ceccatelli and Bruce Cottrill and Michael Dinovi and Bettina Grasl-Kraupp and Christer Hogstrand and Hoogenboom, {Laurentius (Ron)} and Nebbia, {Carlo Stefano} and Oswald, {Isabelle P.} and Annette Petersen and Martin Rose and Alain-Claude Roudot and Tanja Schwerdtle and Christiane Vleminckx and G{\"u}nter Vollmer and Heather Wallace and {De Saeger}, Sarah and Eriksen, {Gunnar Sundst{\o}l} and Peter Farmer and Jean-Marc Fremy and Gong, {Yun Yun} and Karsten Meyer and Hanspeter Naegeli and Dominique Parent-Massin and {van Egmond}, Hans and Andrea Altieri and Paolo Colombo and Mari Eskola and {van Manen}, Mathijs and Lutz Edler and {EFSA Panel on Contaminants in the Food Chain (CONTAM)}",
note = "The CONTAM Panel wishes to acknowledge all European competent authorities and other stakeholders that provided occurrence data on moniliformin in food and feed, and supported the consumption data collection for the Comprehensive European Food Consumption Database. Adopted: 21 November 2017",
year = "2018",
month = "3",
doi = "10.2903/j.efsa.2018.5082",
language = "English",
volume = "16",
journal = "EFSA Journal",
issn = "1831-4732",
publisher = "John Wiley & Sons, Ltd",
number = "3",

}

TY - JOUR

T1 - Risks to human and animal health related to the presence of moniliformin in food and feed

AU - Knutsen, Helle Katrine

AU - Alexander, Jan

AU - Barregård, Lars

AU - Bignami, Margherita

AU - Brüschweiler, Beat

AU - Ceccatelli, Sandra

AU - Cottrill, Bruce

AU - Dinovi, Michael

AU - Grasl-Kraupp, Bettina

AU - Hogstrand, Christer

AU - Hoogenboom, Laurentius (Ron)

AU - Nebbia, Carlo Stefano

AU - Oswald, Isabelle P.

AU - Petersen, Annette

AU - Rose, Martin

AU - Roudot, Alain-Claude

AU - Schwerdtle, Tanja

AU - Vleminckx, Christiane

AU - Vollmer, Günter

AU - Wallace, Heather

AU - De Saeger, Sarah

AU - Eriksen, Gunnar Sundstøl

AU - Farmer, Peter

AU - Fremy, Jean-Marc

AU - Gong, Yun Yun

AU - Meyer, Karsten

AU - Naegeli, Hanspeter

AU - Parent-Massin, Dominique

AU - van Egmond, Hans

AU - Altieri, Andrea

AU - Colombo, Paolo

AU - Eskola, Mari

AU - van Manen, Mathijs

AU - Edler, Lutz

AU - EFSA Panel on Contaminants in the Food Chain (CONTAM)

N1 - The CONTAM Panel wishes to acknowledge all European competent authorities and other stakeholders that provided occurrence data on moniliformin in food and feed, and supported the consumption data collection for the Comprehensive European Food Consumption Database. Adopted: 21 November 2017

PY - 2018/3

Y1 - 2018/3

N2 - Moniliformin (MON) is a mycotoxin with low molecular weight primarily produced by Fusarium fungi and occurring predominantly in cereal grains. Following a request of the European Commission, the CONTAM Panel assessed the risk of MON to human and animal health related to its presence in food and feed. The limited information available on toxicity and on toxicokinetics in experimental and farm animals indicated haematotoxicity and cardiotoxicity as major adverse health effects of MON. MON causes chromosome aberrations in vitro but no in vivo genotoxicity data and no carcinogenicity data were identified. Due to the limitations in the available toxicity data, human acute or chronic health‐based guidance values (HBGV) could not be established. The margin of exposure (MOE) between the no‐observed‐adverse‐effect level (NOAEL) of 6.0 mg/kg body weight (bw) for cardiotoxicity from a subacute study in rats and the acute upper bound (UB) dietary exposure estimates ranged between 4,000 and 73,000. The MOE between the lowest benchmark dose lower confidence limit (for a 5% response ‐ BMDL05) of 0.20 mg MON/kg bw per day for haematological hazards from a 28‐day study in pigs and the chronic dietary human exposure estimates ranged between 370 and 5,000,000 for chronic dietary exposures. These MOEs indicate a low risk for human health but were associated with high uncertainty. The toxicity data available for poultry, pigs, and mink indicated a low or even negligible risk for these animals from exposure to MON in feed at the estimated exposure levels under current feeding practices. Assuming similar or lower sensitivity as for pigs, the CONTAM Panel considered a low or even negligible risk for the other animal species for which no toxicity data suitable for hazard characterisation were identified. Additional toxicity studies are needed and depending on their outcome, the collection of more occurrence data on MON in food and feed is recommended to enable a comprehensive human risk assessment.

AB - Moniliformin (MON) is a mycotoxin with low molecular weight primarily produced by Fusarium fungi and occurring predominantly in cereal grains. Following a request of the European Commission, the CONTAM Panel assessed the risk of MON to human and animal health related to its presence in food and feed. The limited information available on toxicity and on toxicokinetics in experimental and farm animals indicated haematotoxicity and cardiotoxicity as major adverse health effects of MON. MON causes chromosome aberrations in vitro but no in vivo genotoxicity data and no carcinogenicity data were identified. Due to the limitations in the available toxicity data, human acute or chronic health‐based guidance values (HBGV) could not be established. The margin of exposure (MOE) between the no‐observed‐adverse‐effect level (NOAEL) of 6.0 mg/kg body weight (bw) for cardiotoxicity from a subacute study in rats and the acute upper bound (UB) dietary exposure estimates ranged between 4,000 and 73,000. The MOE between the lowest benchmark dose lower confidence limit (for a 5% response ‐ BMDL05) of 0.20 mg MON/kg bw per day for haematological hazards from a 28‐day study in pigs and the chronic dietary human exposure estimates ranged between 370 and 5,000,000 for chronic dietary exposures. These MOEs indicate a low risk for human health but were associated with high uncertainty. The toxicity data available for poultry, pigs, and mink indicated a low or even negligible risk for these animals from exposure to MON in feed at the estimated exposure levels under current feeding practices. Assuming similar or lower sensitivity as for pigs, the CONTAM Panel considered a low or even negligible risk for the other animal species for which no toxicity data suitable for hazard characterisation were identified. Additional toxicity studies are needed and depending on their outcome, the collection of more occurrence data on MON in food and feed is recommended to enable a comprehensive human risk assessment.

KW - moniliformin

KW - MON

KW - exposure

KW - toxicity

KW - occurence

KW - human and animal risk assessment

U2 - 10.2903/j.efsa.2018.5082

DO - 10.2903/j.efsa.2018.5082

M3 - Article

VL - 16

JO - EFSA Journal

JF - EFSA Journal

SN - 1831-4732

IS - 3

M1 - e05082

ER -